Matches in Wikidata for { <http://www.wikidata.org/entity/Q64173430> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q64173430 description "assaig clínic" @default.
- Q64173430 description "clinical trial" @default.
- Q64173430 description "clinical trial" @default.
- Q64173430 description "clinical trial" @default.
- Q64173430 description "clinical trial" @default.
- Q64173430 description "ensaio clínico" @default.
- Q64173430 description "ensayo clínico" @default.
- Q64173430 description "ensayu clínicu" @default.
- Q64173430 description "essai clinique" @default.
- Q64173430 description "klinisch onderzoek" @default.
- Q64173430 description "клінічне випробування" @default.
- Q64173430 name "Nab-PCE vs PC for MM After Failure of Anti-PD-1" @default.
- Q64173430 type Item @default.
- Q64173430 label "Nab-PCE vs PC for MM After Failure of Anti-PD-1" @default.
- Q64173430 prefLabel "Nab-PCE vs PC for MM After Failure of Anti-PD-1" @default.
- Q64173430 P1050 Q64173430-D984435F-B019-4DDC-B1C5-800847D62C1E @default.
- Q64173430 P1132 Q64173430-B702140B-529C-408C-BD0F-C23C7A41E675 @default.
- Q64173430 P1476 Q64173430-82B306A1-D30C-41D6-B84A-BE71631EDEFB @default.
- Q64173430 P2899 Q64173430-D0FFC481-3198-4810-8C4C-C20C1992DEC1 @default.
- Q64173430 P3098 Q64173430-733513DF-017E-44BB-AA12-D0FC948FDC52 @default.
- Q64173430 P31 Q64173430-29E14424-F799-4AA7-B9D5-CA9582D4794A @default.
- Q64173430 P4135 Q64173430-DE5A5A56-FDE6-4C35-9214-DA96926A6294 @default.
- Q64173430 P4844 Q64173430-9C2688DC-CFAC-4FDA-8D45-F124EFCF1096 @default.
- Q64173430 P4844 Q64173430-A87393E9-56A5-4C7B-9AA1-D7FABA9D1B18 @default.
- Q64173430 P580 Q64173430-CEF528DE-86C7-4171-A6D9-B9A277594114 @default.
- Q64173430 P582 Q64173430-87C3A171-2D8E-44B2-8208-4B323C95A86F @default.
- Q64173430 P6099 Q64173430-C426C179-9AB5-46B0-90E2-6FA29B9CFE08 @default.
- Q64173430 P8363 Q64173430-DB050D33-44C7-4209-B534-B23273055B33 @default.
- Q64173430 P1050 Q180614 @default.
- Q64173430 P1132 "+145" @default.
- Q64173430 P1476 "Nab-paclitaxel Plus Carboplatin Combined Endostatin Versus Solvent-based Paclitaxel Plus Carboplatin in the Treatment of Advanced Melanoma After the Failure of PD-1 Treatment #A Randomized Controlled, Open, Multicenter Trial" @default.
- Q64173430 P2899 "+18" @default.
- Q64173430 P3098 "NCT03917069" @default.
- Q64173430 P31 Q30612 @default.
- Q64173430 P4135 "+70" @default.
- Q64173430 P4844 Q415588 @default.
- Q64173430 P4844 Q423762 @default.
- Q64173430 P580 "2019-03-23T00:00:00Z" @default.
- Q64173430 P582 "2021-09-30T00:00:00Z" @default.
- Q64173430 P6099 Q42824440 @default.
- Q64173430 P8363 Q78089383 @default.